# FOXN2

## Overview
FOXN2 is a gene that encodes the forkhead box N2 protein, a member of the forkhead family of transcription factors. These proteins are characterized by a distinct forkhead or winged-helix DNA-binding domain, which plays a crucial role in regulating the expression of genes involved in various biological processes, including development, metabolism, and cell cycle control. The forkhead box N2 protein is involved in transcriptional regulation and has been implicated in several cellular pathways that influence cancer progression and prognosis. Alterations in the expression of FOXN2 have been associated with various cancers, including leukemia, lymphoma, and nervous system tumors, as well as clear cell renal cell carcinoma, where it serves as a potential prognostic marker (Jia2018Forkhead‑box; Yin2022An).

## Clinical Significance
FOXN2 is implicated in various cancers due to its altered expression levels. In leukemia, FOXN2 is upregulated in at least four subtypes, including acute myeloid leukemia (AML), suggesting a role in the disease's pathogenesis (Yin2022An). In lymphoma, FOXN2 is differentially expressed in at least five subtypes, indicating its potential involvement in these cancers as well (Yin2022An). Additionally, FOXN2 is differentially expressed in several nervous system tumors, such as glioblastoma and glioma, which may have implications for cancer prognosis and treatment response (Yin2022An).

In clear cell renal cell carcinoma (ccRCC), high levels of FOXN2 expression are associated with favorable outcomes for both overall survival (OS) and disease-free survival (DFS), highlighting its potential as a prognostic marker (Jia2018Forkhead‑box). The study of FOXN2 in ccRCC did not find significant associations with clinical variables such as age, sex, tumor stage, or grade, suggesting that its prognostic value is independent of these factors (Jia2018Forkhead‑box). These findings underscore the clinical significance of FOXN2 in cancer diagnosis and therapy.


## References


[1. (Jia2018Forkhead‑box) Zhongwei Jia, Fangning Wan, Yao Zhu, Guohai Shi, Hailiang Zhang, Bo Dai, and Dingwei Ye. Forkhead‑box series expression network is associated with outcome of clear‑cell renal cell carcinoma. Oncology Letters, April 2018. URL: http://dx.doi.org/10.3892/ol.2018.8405, doi:10.3892/ol.2018.8405. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ol.2018.8405)

[2. (Yin2022An) Haimeng Yin, Xing Fan, Yanqiao Zhang, Nan Zhao, Xiaoyi Zhao, Kehan Yin, and Yali Zhang. An integrated study on the differential expression of the fox gene family in cancer and their response to chemotherapy drugs. Genes, 13(10):1754, September 2022. URL: http://dx.doi.org/10.3390/genes13101754, doi:10.3390/genes13101754. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes13101754)